Skip to main content
Hikal Ltd. logo

Hikal Ltd. — Investor Relations & Filings

Ticker · HIKAL ISIN · INE475B01022 LEI · 335800OLTGHHYZWTF859 BSE.NS Manufacturing
Open in API
Filings indexed 715 across all filing types
Latest filing 2024-11-22 Board/Management Inform…
Country IN India
Listing BSE.NS HIKAL

About Hikal Ltd.

https://www.hikal.com

Hikal Ltd. provides solutions across the life sciences value chain, specializing in the development and manufacturing of active ingredients, intermediates, and formulations. The company operates through two primary business segments: Pharmaceuticals and Crop Protection. In the pharmaceutical division, it focuses on the production of Active Pharmaceutical Ingredients (APIs) and advanced intermediates for various therapeutic areas. The crop protection segment involves the contract manufacturing of pesticides, herbicides, and fungicides for global agrochemical leaders. Hikal offers comprehensive Contract Research and Manufacturing Services (CRAMS), leveraging its research and development capabilities to support clients from early-stage development to commercial-scale production. Its facilities adhere to international quality standards, maintaining a strong track record of regulatory compliance with global health authorities.

Recent filings

Filing Released Lang Actions
Cessation
Board/Management Information Classification · 100% confidence The document is a formal disclosure under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements, 2015, announcing the resignation of a senior employee (Assistant Vice President - Information Technology). It is an announcement of a management change rather than a financial report or other type of filing. The document length is short (1656 characters), and it does not contain financial data or detailed management discussion. Therefore, it fits the category of Board/Management Information (MANG).
2024-11-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of an earnings conference call held on November 12, 2024, discussing the financial and operational performance for the quarter and half year ended September 30, 2024. It includes detailed management commentary on financial results, business segments, strategic initiatives, and a Q&A session with analysts. The presence of a full transcript with management discussion and Q&A clearly identifies this as a Call Transcript (CT). The document is about 15,000 characters long, contains substantive content, and is not merely an announcement or summary. Therefore, it fits the definition of a Call Transcript (CT).
2024-11-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the schedule of an analyst/institutional investor meeting. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30(6), which pertains to disclosure of events or information. The content is an announcement of a meeting schedule, not a financial report, earnings release, or detailed investor presentation. The document length is only 2042 characters, which is quite short and does not contain financial data or detailed analysis. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2024-11-13 English
Copy of Newspaper Publication
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial results for the quarter and half year ended 30th September 2024 for multiple companies, including CHL Limited and Shree Hari Chemicals. It includes unaudited financial data such as total income, net profit/loss, earnings per share, and notes about limited review by statutory auditors. The document references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 33, which pertains to quarterly financial results. The presence of comprehensive financial data and analysis for a period shorter than a full fiscal year (quarter and half year) indicates this is an Interim / Quarterly Report. The document is about 15,000 characters long, which is consistent with a substantive financial report rather than a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2024-11-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the availability of the audio recording of the earnings conference call for the quarter and half ended September 30, 2024. It references the earnings call and provides a link to the audio recording, but does not contain the transcript or detailed financial data itself. The document is short (1462 characters) and serves as an announcement of the availability of the earnings call recording. According to the classification rules, a full transcript of the call would be classified as Call Transcript (CT), but this document is only an announcement of the recording availability, not the transcript itself. Therefore, the best fitting category is Regulatory Filings (RNS) as a general regulatory announcement about the earnings call recording availability.
2024-11-12 English
Press Release
Earnings Release Classification · 100% confidence The document is titled as an "Earnings Press Release on the Results of the Company for the quarter ended September 30, 2024." It contains unaudited standalone and consolidated financial results for Q2 FY25, including revenue, EBITDA, PAT, segmental revenue, and management commentary on performance and outlook. The document is approximately 10,166 characters long, which is sufficient to contain substantive financial data and analysis. It is not merely an announcement of a report or a certification. The content aligns with an Earnings Release, which typically provides key highlights of quarterly financial results and management commentary without the full detailed financial statements found in interim or annual reports. Therefore, the appropriate classification is Earnings Release (ER).
2024-11-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.